Literature DB >> 6288312

Clinical comparison of cimetidine and ranitidine.

D C Brater, M N Peters, F N Eshelman, C T Richardson.   

Abstract

Ranitidine is a histamine H2-receptor antagonist that differs structurally from cimetidine. We assessed its kinetics, potency, and duration of effect in patients with chronic duodenal ulcers. Ranitidine had an absorption lag time of approximately 30 min, an absorption half-life (t 1/2) of approximately 40 min, and an elimination t 1/2 of 3 hr, all differing from those of cimetidine. It is five times as potent, so that equal doses of ranitidine induce considerably longer suppression of both basal and food-stimulated gastric acid secretion than cimetidine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6288312     DOI: 10.1038/clpt.1982.192

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  12 in total

1.  Lack of effect of omeprazole, cimetidine, and ranitidine on the pharmacokinetics of ethanol in fasting male volunteers.

Authors:  K A Jönsson; A W Jones; H Boström; T Andersson
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

3.  Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion.

Authors:  M J Collen; R M Strong
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

4.  Effect of a new potent H2-receptor antagonist on meal-stimulated gastric acid secretion and serum gastrin concentration in duodenal ulcer patients.

Authors:  S Brozinsky; D L Hogan; J I Isenberg; C T Richardson
Journal:  Dig Dis Sci       Date:  1984-02       Impact factor: 3.199

5.  Daytime acid secretion after a single dose of ranitidine and cimetidine--a double blind crossover study.

Authors:  V F Eckardt; I Cordes; H D Janisch; H Wiemann
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Acceleration of rat brain beta-adrenoceptor subsensitivity following the coadministration of histamine receptor antagonists with imipramine.

Authors:  A A Alhaider; A A Mustafa
Journal:  Agents Actions       Date:  1989-11

7.  Refractory duodenal ulcer.

Authors:  K D Bardhan
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

8.  MK-208, a novel histamine H2-receptor inhibitor with prolonged antisecretory effect.

Authors:  R W McCallum; A N Chremos; B Kuljian; M A Tupy-Visich; P B Huber
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

9.  Effect of 11R, 16, 16-trimethyl prostaglandin E2 on meal-stimulated gastric acid secretion in duodenal ulcer subjects.

Authors:  H J Lenz; S Brozinsky; M A Koss; D L Hogan; M L Scheinbaum; J I Isenberg
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 10.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.